In 2024, Viatris reported net sales of 8.9 billion U.S. dollars in developed markets, compared to 9.8 billion U.S. dollars in 2022. This statistic shows the net sales of pharmaceutical company Viatris from 2021 to 2024, distributed by its four regional markets. Viatris is a global healthcare company headquartered in the United States with global centers in Pennsylvania, Shanghai and Hyderabad, India. The company was formed in November 2020 through the combination of Mylan and the Upjohn Business (owned by Pfizer Inc.). Its global portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized iconic brands (such as Viagra, Xanax, Lipitor).
Viatris' net sales from 2022 to 2024, by market
(in million U.S. dollars)
Developed Markets include primarily North America and Europe.
Greater China includes China, Taiwan and Hong Kong.
JANZ reflects operations in Japan, Australia and New Zealand.
Emerging Markets encompass operations in countries with developing markets and emerging economies including countries in Asia, the
Middle East, South and Central America, Africa and Eastern Europe, and also includes the company’s anti-retroviral franchise.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Viatris, & U.S. Securities and Exchange Commission. (February 27, 2025). Viatris' net sales from 2022 to 2024, by market (in million U.S. dollars) [Graph]. In Statista. Retrieved June 04, 2025, from https://www.statista.com/statistics/1234934/viatris-net-sales-by-regional-market/
Viatris, und U.S. Securities and Exchange Commission. "Viatris' net sales from 2022 to 2024, by market (in million U.S. dollars) ." Chart. February 27, 2025. Statista. Accessed June 04, 2025. https://www.statista.com/statistics/1234934/viatris-net-sales-by-regional-market/
Viatris, U.S. Securities and Exchange Commission. (2025). Viatris' net sales from 2022 to 2024, by market (in million U.S. dollars) . Statista. Statista Inc.. Accessed: June 04, 2025. https://www.statista.com/statistics/1234934/viatris-net-sales-by-regional-market/
Viatris, and U.S. Securities and Exchange Commission. "Viatris' Net Sales from 2022 to 2024, by Market (in Million U.S. Dollars) ." Statista, Statista Inc., 27 Feb 2025, https://www.statista.com/statistics/1234934/viatris-net-sales-by-regional-market/
Viatris & U.S. Securities and Exchange Commission, Viatris' net sales from 2022 to 2024, by market (in million U.S. dollars) Statista, https://www.statista.com/statistics/1234934/viatris-net-sales-by-regional-market/ (last visited June 04, 2025)
Viatris' net sales from 2022 to 2024, by market (in million U.S. dollars) [Graph], Viatris, & U.S. Securities and Exchange Commission, February 27, 2025. [Online]. Available: https://www.statista.com/statistics/1234934/viatris-net-sales-by-regional-market/
